Post
2) I suspect the media attention is mostly driven by commercial interests, rather than the significance of the scientific findings. The paper comes from the company Oxford BioDynamics (OBD) that developed a new test called EpiSwitch which they applied to ME/CFS.
0 reposts10 likes
6) More critical comments, including from ME/CFS experts such as Prof Chris Ponting and Dr Sjoerd Beentjes can be found below. They say e.g. that it's difficult to evaluate the methods in details because the computational methods used are proprietary. www.sciencemediacent...